KESHAV
USD 186.67
Sold 2,300+Offline Hong Kong pharmacy with 100% genuine product guarantee
Indicated for adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
10000 in stock
Indicated for adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
Mavacamten How It Works How It Works ，
2 (2.1) 2.1 ， [ Precautions(5.4)] (LVEF) CAMZYOS
5 Precautions • ， CAMZYOS 2.1，5.1 • ， 4，5.2，17 • - 4 5.4，7.2，8.1，8.3 5.1 CAMZYOS ，
11 CAMZYOS mavacamten ， 3-(1- )-6-[[(1S)-1- ] ]-2,4(1H,3H)- C15H19N3O2， 273.33 g/mol ， pH 2-10 ， ， DMSO NMP CAMZYOS 2 ， 2.5 5 10 15 ，
Indicated for adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
2 (2.1) 2.1 ， [ Precautions(5.4)] (LVEF) CAMZYOS
5 Precautions • ， CAMZYOS 2.1，5.1 • ， 4，5.2，17 • - 4 5.4，7.2，8.1，8.3 5.1 CAMZYOS ，
8.1 ，CAMZYOS CAMZYOS ， Precautions ， CAMZYOS - ， mavacamten / ，
12 12.1 How It Works Mavacamten Mavacamten “ ” ， - (HCM) Mavacamten HCM ， Mavacamten
13 13.1 Ames ，Mavacamten 6 rasH2 ， 2.0 mg/kg， 3.0 mg/kg， 2 ， 0.6 mg/kg， AUC MRHD AUC 3 0.2 ， 1.2 mg/kg/ ， 1.5 mg/kg/
14 EXPLORER-HCM EXPLORER-HCM (NCT-03470545) CAMZYOS III ， 251 NYHA II III (HCM) ， (LVEF) ≥55%， (LVOT) ≥50 mmHg β HCM 1:1 ， 5 mg CAMZYOS ， ， 30
Indications
Indicated for adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
How It Works
Mavacamten How It Works How It Works ，
Dosage
2 (2.1) 2.1 ， [ Precautions(5.4)] (LVEF) CAMZYOS
Precautions
5 Precautions • ， CAMZYOS 2.1，5.1 • ， 4，5.2，17 • - 4 5.4，7.2，8.1，8.3 5.1 CAMZYOS ，
